These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17334044)

  • 1. Lymphocyte ceruloplasmin and Behçet's disease.
    Oliveira R; Banha J; Martins F; Paixão E; Pereira D; Barcelos F; Teixeira A; Patto JV; Costa L
    Acta Reumatol Port; 2006; 31(4):323-9. PubMed ID: 17334044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between inflammation, iron metabolism and endothelial function in Behçet's disease.
    Oliveira R; Napoleão P; Banha J; Paixão E; Bettencourt A; da Silva BM; Pereira D; Barcelos F; Teixeira A; Patto JV; Viegas-Crespo AM; Costa L
    Clin Hemorheol Microcirc; 2014; 56(2):175-85. PubMed ID: 23619201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum oxidant/antioxidant status in patients with Behçet's disease.
    Taysi S; Kocer I; Memisogullari R; Kiziltunc A
    Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.
    Hamzaoui K; Hamzaoui A; Zakraoui L; Chabbou A
    Mediators Inflamm; 1999; 8(2):101-6. PubMed ID: 10704147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum ferritin levels in active Behçet's disease.
    Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H
    Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine: an activity marker in Behçet's disease?
    Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil CD64 expression in Behçet's disease.
    Ureten K; Ertenli I; Oztürk MA; Kiraz S; Onat AM; Tuncer M; Okur H; Akdogan A; Apras S; Calgüneri M
    J Rheumatol; 2005 May; 32(5):849-52. PubMed ID: 15868620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease.
    Canpolat F; Unver M; Eskioğlu F; Kösebalaban S; Durmazlar SP
    Int J Dermatol; 2006 Sep; 45(9):1053-6. PubMed ID: 16961545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceruloplasmin expression by human peripheral blood lymphocytes: a new link between immunity and iron metabolism.
    Banha J; Marques L; Oliveira R; Martins Mde F; Paixão E; Pereira D; Malhó R; Penque D; Costa L
    Free Radic Biol Med; 2008 Feb; 44(3):483-92. PubMed ID: 17991445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micronucleus frequency in the oral mucosa and lymphocytes of patients with Behçet's disease.
    Hamurcu Z; Dönmez-Altuntas H; Borlu M; Demirtas H; Asçioslu O
    Clin Exp Dermatol; 2005 Sep; 30(5):565-9. PubMed ID: 16045693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet's disease.
    Lew W; Chang JY; Jung JY; Bang D
    Br J Dermatol; 2008 Mar; 158(3):505-11. PubMed ID: 18205865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancies of NKT cells expression in peripheral blood and in cerebrospinal fluid from Behçet's disease.
    Hamzaoui K; Kamoun M; Houman H; Hentati F; Hamza M; Ayed K; Hamzaoui A
    J Neuroimmunol; 2006 Jun; 175(1-2):160-8. PubMed ID: 16624421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
    Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
    J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral insulin resistance in patients with Behçet's disease.
    Erdem H; Dinc A; Pay S; Simsek I; Turan M
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):391-5. PubMed ID: 16643134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis?
    Curnow SJ; Pryce K; Modi N; Knight B; Graham EM; Stewart JE; Fortune F; Stanford MR; Murray PI; Wallace GR
    Immunol Lett; 2008 Nov; 121(1):7-12. PubMed ID: 18706446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
    Hamzaoui K; Hamzaoui A; Ghorbel I; Khanfir M; Houman H
    Scand J Immunol; 2006 Dec; 64(6):655-60. PubMed ID: 17083622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased erythrocyte deformability in Behçet's disease.
    Usküdar O; Erdem A; Demiroğlu H; Dikmenoğlu N
    Clin Hemorheol Microcirc; 2005; 33(2):89-94. PubMed ID: 16151256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipoprotein (a) levels and Behçet's disease: is there an association?
    Balik O; Gur G; Lenk N; Artuz F; Alli N
    Int J Dermatol; 2007 Aug; 46(8):827-9. PubMed ID: 17651165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation and red blood cell phosphatidylserine exposure evaluated by flow cytometry in patients with Behçet's disease: are they related to thrombotic events?
    Martínez M; Ricart JM; Ruiz-Aja S; Rus A; Todolí J; Calvo J; Vayá A
    Pathophysiol Haemost Thromb; 2007; 36(1):18-22. PubMed ID: 18332610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.